Dr RR Baliga's "Got Knowledge Doc" Podkast

Yajnavalkya: Vedic Sage • Radical Thinker • Timeless Voice 🕉️📜✨ What does it mean to know the Self? Long before modern philosophy, Yajnavalkya in the Brihadaranyaka Upanishad asked—and answered—with striking clarity. "Neti, Neti" (not this, not this) strips illusion, revealing the essence of consciousness—Atman as Brahman. In dialogues with Maitreyi and Gargi, he models fearless inquiry, intellectual rigor, and spiritual depth. Ancient, yet urgent. Subtle, yet transformative. #IndianPhilosophy #Vedanta #Yajnavalkya #Consciousness #Wisdom

Emerging insights from Nature Spotlight on Nutrition sharpen a simple truth: what we eat matters—but when and how may matter just as much. Morning coffee aligns with lower cardiovascular mortality, plant-forward diets sculpt a favorable microbiome, early-life sugar exposure imprints lifelong risk, and not all potatoes are equal—fried forms carry harm, not the humble baked. Nutrition is no longer advice—it is biology, timing, and destiny intertwined.

Dopamine is not just the "pleasure chemical"—it is the brain's teaching signal 🧠✨ New insights (from Nature) suggest dopamine shapes how we learn, prioritize, and act—not only through reward, but also via attention, action, and even threat detection 🎯🔁 This evolving paradigm has profound implications for ADHD, addiction, and behavioral medicine 🩺 I've summarized the science into a concise slide deck for clinicians and learners. Curious to hear your thoughts—are we ready to move beyond the reward model? 🚀

A striking study in Science Translational Medicine reveals that the blood–brain barrier remains disrupted years after retirement in contact-sport athletes. This persistent leakiness is linked to systemic inflammation, complement activation, and measurable cognitive decline. Notably, imaging of BBB dysfunction outperformed conventional blood biomarkers—offering a potential path toward early detection of CTE risk in living individuals. The key insight: it's not single concussions, but the cumulative burden of head trauma that shapes long-term brain health.

The thymus—long dismissed as vestigial in adults—re-emerges as a powerful biomarker of health and therapeutic response. Two Nature (2026) studies demonstrate that AI-derived thymic health independently predicts all-cause mortality, cardiovascular death, and cancer risk, while also forecasting immunotherapy outcomes across tumor types—performing comparably to PD-L1 and tumor mutation burden. This reframes aging as an immunologic continuum. The thymus may not just reflect health—it may define it. #PrecisionMedicine #Immunology #CardioOncology #AIinMedicine

A quiet shift is underway in metabolic medicine. A recent Nature study shows that continuous data from wearables—heart rate, sleep, activity—combined with routine labs can detect insulin resistance years before traditional tests. Not snapshots, but a "movie" of physiology. This opens a wider window for prevention: simpler interventions, earlier action, better outcomes. The future may lie not in waiting for thresholds, but in tracking trajectories. #Nature #PrecisionHealth #Wearables #DiabetesPrevention #CardioMetabolic

LVAD patients are increasingly encountered in emergency rooms and ICUs, yet many clinicians remain uncertain about initial management. A recent JACC State-of-the-Art Review provides a practical framework for recognizing and treating LVAD emergencies, from pump thrombosis and right-heart failure to arrhythmias and GI bleeding. Key pearls: LVAD patients may lack a palpable pulse, Doppler is preferred for MAP measurement, and Chest compressions should not be delayed if cardiac arrest is confirmed. First check power connection Understanding pump parameters and echocardiographic clues can rapidly guide diagnosis and life-saving therapy.

Jiddu Krishnamurti challenged one of humanity's deepest assumptions—that wisdom must come from teachers, traditions, or systems. Instead, he argued that genuine understanding begins with self-observation and choiceless awareness. In this short slide set, I summarize the life and ideas of Jiddu Krishnamurti (1895–1986)—the thinker who famously declared: "Truth is a pathless land." 📚 The slides explore: • His early life and break from the Theosophical movement • Core ideas from Freedom from the Known • The role of education and self-inquiry • Why his ideas still resonate in psychology, philosophy, and education 👩‍⚕️ I also included a special slide connecting his insights to healthcare practice, highlighting how self-awareness and attentive observation can deepen patient care. Krishnamurti once suggested that real change begins not in systems—but in the transformation of the mind itself. Curious to explore? #Philosophy #Krishnamurti #FreedomFromTheKnown #SelfAwareness #Consciousness #Education #Psychology #Mindfulness #CriticalThinking #LifelongLearni

🧠🦠 Microbes. Metabolites. Memory. A fascinating new Nature study reveals a gut–brain pathway driving age-related cognitive decline. Expansion of Parabacteroides goldsteinii in aging microbiomes increases medium-chain fatty acids, activating GPR84 signaling in peripheral myeloid cells. The resulting inflammation suppresses vagal sensory signaling, blunting hippocampal neuronal activation and impairing memory. Even more intriguing: interventions restoring gut–brain communication improved cognition in mice. This work highlights the gut microbiome as a therapeutic target for cognitive aging—suggesting that microbiome modulation, vagal stimulation, or GPR84 inhibition may one day help protect memory.

Lipids remain central to cardiovascular prevention. The 2026 ACC/AHA Dyslipidemia Guideline introduces several important shifts: • PREVENT equations replace older ASCVD risk calculators • Lipoprotein(a) measurement recommended at least once in all adults • ApoB helps identify residual lipoprotein risk • Coronary artery calcium scoring refines treatment decisions • LDL-C targets return, with • South Asian ancestry is treated as a "risk enhancer," Earlier identification and aggressive risk reduction remain the cornerstone of preventing atherosclerotic cardiovascular disease. Reference: Blumenthal RS et al. JACC 2026.

🧬🧠❤️ The Immune System Is Not Just Defense — It Is Physiology A superb Science Review (Nahrendorf, Ginhoux, Swirski, 2025) reframes immunity as a systems integrator, shaping brain function, heart rhythm, metabolism, pregnancy, and tissue repair—quietly maintaining homeostasis across the lifespan. Immune cells are not visitors; they are residents, communicators, and regulators in every organ system. 🧩 Defense meets regulation. 🧩 Immunology meets physiology. 📖 Science, August 2025 — a must-read for clinicians, physiologists, and systems thinkers.

A fascinating new study reveals a previously underappreciated pathway for tau clearance in the brain. Researchers show that tanycytes—specialized hypothalamic glial cells—actively transport tau from cerebrospinal fluid into the bloodstream. In Alzheimer disease, these cells become fragmented and dysfunctional, impairing tau clearance and potentially accelerating neurodegeneration. This work opens an intriguing avenue: could restoring tanycyte function enhance tau removal and slow Alzheimer progression? A small cellular gatekeeper may hold an important clue in the battle against dementia. Source: Sauvé F et al. Tanycytic degeneration impairs tau clearance and contributes to Alzheimer's disease pathology. Cell Press Blue, 2026.

Obesity is not simply excess weight—it is a metabolic and inflammatory state that can reshape cancer biology. Adipose tissue alters hormones, insulin signaling, inflammatory cytokines, and immune responses, creating conditions that favor tumor development. Evidence now links obesity with cancers of the breast, colon, endometrium, pancreas, liver, kidney, and esophagus. Understanding these mechanisms opens the door to precision prevention strategies, from weight management to metabolic therapies. The message from translational science is clear: metabolism and malignancy are deeply intertwined. #CancerResearch #ObesityScience #TranslationalMedicine

🧬 Apolipoprotein M (ApoM) is emerging as a key regulator of vascular biology. ApoM, an HDL-associated lipocalin, transports sphingosine-1-phosphate (S1P) and selectively activates S1PR1 signaling in endothelial cells. This pathway stabilizes the endothelial barrier, promotes nitric-oxide mediated vasodilation, and suppresses vascular inflammation. Clinical studies increasingly link lower ApoM levels with cardiometabolic disease, CKD, and heart failure risk. New therapies—including ApoM-fusion biologics and selective S1PR1 agonists—may harness this pathway for vascular protection. The ApoM–S1P axis may represent a new frontier in precision cardiovascular medicine.

📚 Simone de Beauvoir (1908–1986) — philosopher, writer, and architect of modern feminism. Her groundbreaking book The Second Sex (1949) reshaped global conversations on gender with one powerful line: "One is not born, but becomes, a woman." She challenged stereotypes, defended women's autonomy, and influenced second-wave feminism worldwide. Her ideas still echo in medicine, education, ethics, and leadership today. Freedom. Responsibility. Equality. 💡✊📖

🫁 Pulmonary Embolism in 2026 — A Precision Framework The new AHA/ACC Acute Pulmonary Embolism Guideline redefines how we classify and treat PE. Key updates: • Category A–E clinical classification integrating hemodynamics, biomarkers, and RV imaging • Age-adjusted D-dimer and YEARS algorithm to reduce unnecessary imaging • CT pulmonary angiography as preferred diagnostic modality • RV/LV ratio reporting for objective risk stratification • LMWH → DOAC preferred for anticoagulation • Advanced therapies for cardiopulmonary failure • Mandatory 1-year follow-up to screen for CTEPD The message is clear: Stratify early. Treat precisely. Monitor longitudinally.

Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting ~37.6 million people globally, with prevalence expected to double in the coming decades. A recent Lancet Seminar (2026) highlights several key principles shaping modern AF care: • Stroke prevention with oral anticoagulation remains the cornerstone • Early rhythm control strategies improve cardiovascular outcomes • Catheter ablation is increasingly used as first-line therapy • Lifestyle modification—weight loss, exercise, alcohol reduction—reduces AF burden • Integrated care models such as the ABC pathway and AF-CARE improve outcomes The future of AF management is holistic, preventive, and patient-centred. #Cardiology #AtrialFibrillation #StrokePrevention #Electrophysiology #PrecisionMedicine

🧬✨ Can we make the ageing immune system young again? A fascinating Nature study shows that a three-part mRNA cocktail (DFI) can temporarily rejuvenate T cells in aged mice, improving responses to vaccines and cancer immunotherapy—without breaking immune tolerance. By turning the liver into a short-term factory for key immune signals (DLL1, FLT3L, IL-7), the authors demonstrate that immune ageing is modifiable, not fixed. This elegant work—covered by Heidi Ledford in Nature—opens provocative questions about immune resilience, ageing biology, and the future of mRNA beyond vaccines. 🧠🛡️ 📄 Friedrich MJ et al., Nature 2025 | News & Views: Ledford H. 🔗 doi:10.1038/s41586-025-09873-4 | doi:10.1038/d41586-025-04082-5

🧬 Protein Restriction, Aging, and Longevity ⏳ A remarkable new study in Cell shows that moderate protein restriction—especially when started in midlife—can reprogram aging biology across 41 organs, improving metabolic and cardiovascular health. 🫀⚙️ Using deep multi-organ proteomics in mice and human plasma validation, the authors demonstrate benefits mediated through ↓ IGF-1, ↓ mTOR, ↑ AMPK, and activation of brown adipose tissue. Importantly, the data also caution that extreme protein restriction may provoke inflammation, underscoring that moderation matters. ⚠️🎯 A powerful example of how nutrition shapes the biology of aging—organ by organ, pathway by pathway. 📖 Cell (2025) #Aging #Longevity #ProteinRestriction #MetabolicHealth #CardiovascularHealth #Proteomics #PrecisionNutrition

Resistant hypertension remains one of the most stubborn challenges in cardiovascular medicine. The Bax24 phase 3 trial, published in The Lancet (2026), evaluated baxdrostat, a selective aldosterone synthase inhibitor, in patients already receiving multiple antihypertensive agents. Key findings: • −16.6 mmHg reduction in 24-hour ambulatory SBP • −14.0 mmHg placebo-corrected difference (p • 71% achieved BP control ( • Acceptable safety profile, with hyperkalemia in 3% These data highlight the growing importance of aldosterone dysregulation in resistant hypertension and suggest that targeted aldosterone synthase inhibition may represent a new therapeutic frontier. Reference: Azizi M et al. Effect of Baxdrostat on Ambulatory Blood Pressure in Resistant Hypertension (Bax24). Lancet 2026.

🏃‍♀️🏋️‍♂️ Does variety in physical activity matter for longevity? A large prospective analysis suggests it does: people who engaged in a wider mix of activity types tended to have lower all-cause mortality, even after accounting for total activity and key covariates. 🌈📉 Key practical takeaway: don't just "do more"—do different (walk + cycle + swim + strength, etc.). ✅🫀 As always, this is observational data (residual confounding + self-report remain). Still, it's a compelling nudge toward diversity in movement as a realistic, patient-friendly goal. 💡👟 #PhysicalActivity #Prevention #Cardiology #PublicHealth #LifestyleMedicine

Chronic diarrhea affects approximately 6–7% of adults, and the vast majority of cases are noninfectious. The most common causes are irritable bowel syndrome with diarrhea and functional diarrhea. A systematic approach matters: • Screen with CBC, CMP, fecal calprotectin, IgA-tTG • Identify alarm features • Biopsy for microscopic colitis when needed • Start with lifestyle + low-FODMAP • Escalate to targeted therapy thoughtfully Precision in diagnosis leads to precision in therapy. #Gastroenterology #InternalMedicine #EvidenceBasedMedicine

Jean-Paul Sartre (1905–1980) forced a generation to confront a radical idea: existence precedes essence. We are not born with a fixed nature — we create ourselves through choices. That freedom is powerful… and unsettling. 🧠 In Being and Nothingness and Existentialism Is a Humanism, Sartre explored authenticity vs. "bad faith" — the temptation to hide from responsibility. Philosopher, playwright, activist, public intellectual — he believed ideas must live in the world. ✍️🔥 Freedom is not optional. It is our condition.

Can lifting light weights help lift grades? 💪📚 A recent cross-sectional study reports that adolescents engaging in regular muscle-strengthening exercise demonstrated better performance in literacy, mathematics, and language outcomes. 📊🧠 Even after adjusting for sociodemographic and lifestyle factors, the association persisted—highlighting a potential link between resistance training and cognitive or academic performance. For clinicians, educators, and policymakers, this reinforces a simple message: physical strength and intellectual growth may not be separate domains—they may be synergistic. Train the body. Shape the brain. Elevate the future. 💪✨

Type 1 Diabetes is more than high sugar — it is autoimmunity, absolute insulin deficiency, and lifelong vigilance. 🧬💉 Early recognition of polyuria, polydipsia, and weight loss can prevent diabetic ketoacidosis. Timely diagnosis with islet autoantibodies and C-peptide testing guides care. 📊 Modern insulin strategies and continuous glucose monitoring have transformed outcomes — yet microvascular and macrovascular risks remain. Precision, persistence, partnership. 🩺

Sepsis: Detect. Treat. Survive. Sepsis remains a major global health threat, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Early recognition, prompt antibiotics, and timely hemodynamic support save lives. ⏱️💉💧 The latest The Lancet Seminar (Feb 26, 2026) highlights evolving definitions, pathobiology, global burden, and the need for precision-guided care. 🌍🧬 From prevention to recovery, sepsis demands vigilance across all health systems. 🚑🏥 #Sepsis #CriticalCare #Infection #ICU #PatientSafety

Can the aging brain still make new neurons? A landmark 2026 Nature study analyzed 355,997 human hippocampal nuclei using single-nucleus RNA sequencing and ATAC sequencing. Neurogenesis persists into adulthood—but chromatin accessibility collapses early in Alzheimer's disease. SuperAgers showed a 2.5-fold increase in immature neurons and a preserved resilience signature. Epigenetics may be the earliest battlefield in cognitive decline. 🧠

Radiation. Regions. Responsibility. 🌍⚡ A JAMA study (INCAPS-4) analyzing 19,302 patients across 101 countries reveals striking global disparities in radiation exposure from cardiac imaging. Median CCTA dose in Africa: 25.2 mSv Western Europe: 4.6 mSv Low-income nations had 96% higher CCTA doses. Technology and training—not just access—determine safety. As CAD rises worldwide, dose optimization must become a global quality benchmark.

Can a single bolus change the fate of a devastating stroke? 🧠💉 The TRACE-5 trial (Lancet 2026) shows that tenecteplase within 24 h for basilar artery occlusion improves excellent functional outcomes (38% vs 29%; RR 1.50, p=0.014) without increased haemorrhage or mortality. 📊 Pragmatic design. No mandatory advanced imaging. Feasible globally. 🌍 If confirmed beyond Asian cohorts, this could reshape late-window stroke care. Single shot. Shifted scale. Strong signal. 🚑📈

Ludwig Wittgenstein (1889–1951) reshaped modern philosophy by asking a deceptively simple question: How does language work? 🧠 In the Tractatus, he argued that language "pictures" reality — and that what cannot be clearly said must be passed over in silence. Later, in Philosophical Investigations, he reversed course: meaning is not fixed — it is use, embedded in "language games." 🎯 His lasting insight? Many philosophical problems are really linguistic confusions. Clarity is not cosmetic — it is transformative. ✨ In medicine, law, policy, or everyday life, careful language is careful thinking

Light smoking is not harmless. 🚬 A powerful New England Journal of Medicine Perspective highlights the rising challenge of nondaily and low-intensity smokers in Latin America. Even fewer than 10 cigarettes per day carry meaningful cardiovascular and cancer risk — yet these smokers often underestimate harm and receive limited cessation support. The future of tobacco control must address the "light" smoker with tailored counseling, pharmacotherapy, and smarter primary-care integration.

🧠 Alzheimer's doesn't begin when memory fails — it begins years earlier. A new Cell Reports Medicine study identifies PPP2R5C, a brain-derived protein detectable in blood, that declines before significant Tau hyperphosphorylation. 📉 ↓ 61% in amnestic mild cognitive impairment 📊 AUC 0.85 for Alzheimer's diagnosis 🔬 Mechanism: activates Protein Phosphatase 2A and ULK1-driven autophagy to regulate Tau A blood signal before symptoms. Early detection means earlier intervention.

🧠 Can a simple blood test tell us when Alzheimer's symptoms will begin? A new Nature Medicine study introduces a plasma p-tau217 "molecular clock" that estimates time to symptom onset with an error margin of ~3–4 years. By modeling the rise of phosphorylated tau in cognitively unimpaired individuals, investigators move from predicting if to predicting when. ⏳ Implication: smarter prevention trials, earlier intervention windows, and biologically timed enrollment. ⚠️ Not ready for routine screening—but a compelling proof of concept. The era of temporal precision in neurodegeneration may have begun.

The brain's "skull drains" are far from passive plumbing. In Nature (2026), Monaghan et al. show that dural venous sinuses actively constrict, dilate, and even rearrange endothelial borders in a phenomenon called "ruffling" to support immune surveillance. RAMP1 regulates vasomotion. RAMP2 regulates immune boundary dynamics. Blocking RAMP2 impairs antiviral defense. The meninges are not coverings. They are regulated neuroimmune interfaces. 🧠🛡️

Can we finally modulate post-stroke inflammation? 🧠 The EMPHASIS trial (Lancet 2026) randomized 1,724 patients with acute ischemic stroke to short-course oral minocycline within 72h. Result: higher rates of excellent 90-day outcome (mRS 0–1 52.6% vs 47.4%; RR 1.11, p=0.0061) without safety concerns. A cheap, generic drug showing signal in late neuroprotection. Inflammation may not just follow stroke — it may shape recovery. 🔬

🦴 Rotator cuff "tears" are nearly universal after age 40. In a population-based Finnish study (n=602), 99% had ≥1 MRI abnormality — including 96% of asymptomatic shoulders. Even full-thickness tears were usually silent, and adjusted analyses eliminated differences between painful and painless shoulders . Lesson? After 40, imaging abnormalities are common — causality is not. Treat function. Treat symptoms. Treat patients — not scans.

Sri Aurobindo (1872–1950) lived two extraordinary lives in one lifetime — revolutionary nationalist and visionary yogi. From the Alipore trial to the quietude of Pondicherry, he shifted the conversation from political freedom to inner evolution. His Integral Yoga proposed something radical: not escape from the world, but transformation of it — a movement from mind to "Supermind," from human to supramental consciousness. The Life Divine, The Synthesis of Yoga, and Savitri remain profound explorations of human potential and spiritual evolution. A thinker of synthesis — East and West, action and contemplation, nation and cosmos.

Chronic lymphoedema may not just be about fluid. It may be about cholesterol. 🧬 In human tissue and translational mouse models, impaired lymphatic drainage led to excess dermal cholesterol deposition, adipocyte dysfunction, fibrosis, and swelling — even when plasma cholesterol was normal. Clearing tissue cholesterol with cyclodextrin restored lymphatic architecture and reduced oedema. Clear the cholesterol. Restore the flow

Psychedelic medicine is moving from the margins to mainstream neuroscience. 🧠✨ A recent Nature Medicine review synthesizes the biology behind the renaissance: 5-HT2A signaling, acute brain desynchronization, and a subacute plasticity window driven by BDNF–TrkB pathways. The promise is real — rapid effects in depression, PTSD, and addiction — but so are the challenges: expectancy, unblinding, scalability, and safety. Entropy. Plasticity. Psychiatry. 🔬 A field worth watching — carefully, rigorously, and responsibly.

Are statins as risky as labels suggest? 📊 In a 154,664-patient individual-participant meta-analysis of 23 double-blind RCTs, only 4 of 66 listed adverse effects were confirmed — mainly small, dose-related liver enzyme elevations. No causal signal for cognitive decline, depression, sleep disturbance, neuropathy, or kidney injury. Absolute excess risks were tiny ( Cardiovascular benefit still overwhelmingly outweighs risk. Evidence matters. 💡

IgA nephropathy remains the most common immune-mediated glomerular disease worldwide — and up to 50% of patients may progress to kidney failure within a decade. 🧬 The 2025 KDIGO guidance emphasizes early biopsy (proteinuria ≥0.5 g/day), tight BP control ( Proteinuria remains the key modifiable driver. Precision nephrology is here — and measurable. 🩺📉

Genes. Glands. Vessels. 💊 Hypertension therapy is entering a new era. The latest Lancet review highlights RNA-based silencing of angiotensinogen, selective aldosterone synthase inhibition, non-steroidal mineralocorticoid receptor antagonists, endothelin receptor blockade, and natriuretic peptide enhancement. These therapies move beyond ACE inhibitors and ARBs toward durable, mechanism-driven blood pressure control—especially for resistant hypertension and multimorbidity. The future may not be just lowering pressure, but reshaping pathways. 🔬🫀

☕🧠 Can your daily coffee protect your brain? In a JAMA study of 131,821 adults followed for up to 43 years, moderate caffeinated coffee and tea intake was associated with a lower risk of dementia and modestly better cognition. The sweet spot: 2–3 cups of coffee or 1–2 cups of tea per day. Notably, decaffeinated coffee showed no benefit. A compelling population-level prevention signal—simple habits, long horizons, meaningful impact.

Bertrand Russell showed that clear thinking is a moral act 🧠✨ As a founder of analytic philosophy, he taught us to question assumptions, sharpen language, and let logic guide both ideas and action 📐📘 From Principia Mathematica to public debates on freedom and peace, Russell reminds us that clarity, courage, and doubt belong together 🕊️📚

🧠🩸 A finger-prick may change how we detect Alzheimer's disease. A new Nature Medicine study shows that dried capillary blood spots can reliably measure key Alzheimer's biomarkers—p-tau217, GFAP, and neurofilament light—with strong concordance to venous plasma and cerebrospinal fluid results. 📊 In the DROP-AD multicenter study (7 sites, 337 participants), capillary p-tau217 correlated strongly with plasma (r≈0.74) and predicted amyloid pathology with good accuracy (AUC ≈0.86). 🚀 Why this matters: • Enables minimally invasive, scalable, and potentially remote testing • Expands access for population screening, prevention trials, and underserved groups (including Down syndrome) • Moves us closer to earlier, equitable detection—though not yet ready for routine clinical decision-making Small drop. Big signal. The future of Alzheimer's research may be at our fingertips. ✨

🧬 Why Coronary Artery Disease Runs in Families Coronary artery disease is not just lifestyle—it is deeply genetic. Rare monogenic disorders like familial hypercholesterolemia and hundreds of common variants together shape lifelong risk, with polygenic risk scores identifying individuals whose inherited risk rivals traditional factors 🫀. The good news: genetic risk is modifiable. Early LDL lowering, healthy lifestyles, and precision prevention deliver the greatest benefit in those at highest inherited risk 🔬. A timely synthesis from The New England Journal of Medicine (2026) that reframes CAD—from destiny to opportunity.

🧬⚖️ Cancer and Acute Coronary Syndromes: Precision Where It Matters Most As cancer survival improves, more patients live long enough to face acute coronary syndromes (ACS)—often with competing risks of death, bleeding, and ischaemia. Yet these patients have been largely excluded from ACS trials, leaving clinicians to navigate uncertainty. A landmark Lancet study introduces ONCO-ACS, the first cancer-specific, externally validated risk tool that simultaneously predicts 6-month mortality, major bleeding, and ischaemic events using 11 routine admission variables. 📊🧠 The result: actionable, bedside precision—helping tailor invasive strategy, antiplatelet intensity, and duration to the dominant risk for each patient. This is a major step toward personalised cardio-oncology care, moving beyond one-size-fits-all scores to nuanced, patient-centred decisions. 🎯💡

🫀 Rethinking DCD Heart Transplantation A new JAMA Original Investigation reports encouraging early outcomes using rapid recovery with extended ultraoxygenated preservation (REUP) for donation after circulatory death (DCD) heart transplantation—without donor heart reanimation or machine perfusion. 🔬 In a 24-patient case series, REUP achieved 96% 30-day survival, low primary graft dysfunction (4%), and minimal early rejection, even with older donors and prolonged ischemic times. ⚖️ By avoiding reanimation, REUP may reduce ethical concerns, cost, and logistical complexity, while expanding the usable donor pool. 🌍 A potentially scalable, globally relevant step forward in transplant medicine. Sometimes progress is not about doing more—but about doing just enough, better.

⏰🧬 Timing matters in cancer. A superb JCI Review, Rhythms of risk: the intersection of clocks, cancer, and chronotherapy, shows how circadian clocks regulate cell cycle, DNA repair, metabolism, immunity, hypoxia, and even metastasis—and how circadian disruption (e.g., night-shift work) can reshape cancer risk and treatment response. ⚖️💊 The takeaway: clock biology is context-specific, and aligning therapy with circadian phase may enhance efficacy while reducing toxicity—an underused lever in precision oncology. 🎯 Worth a careful read for clinicians, scientists, and trialists thinking about the fourth dimension of cancer: time. ⏱️

🫀 Residual Risk in Coronary Artery Disease Even after "optimal" therapy, many patients remain at risk. Why? Because atherosclerosis is more than LDL—it's thrombosis 🩸, inflammation 🔥, and metabolism ⚖️ working in concert. This FAQ-based slide deck distills contemporary insights on residual thrombotic, lipid, metabolic, and inflammatory risk, and highlights emerging therapies—from dual-pathway inhibition 💊 to GLP-1 receptor agonists 🧬 and colchicine—that help close the gap between treatment and outcomes. 📊 Key message: precision, not complacency. #Cardiology #SecondaryPrevention #ResidualRisk #CAD #PrecisionMedicine